Dr. Guido Kroemer on Autophagy, Caloric Restriction Mimetics, Fasting & Protein Acetylation
Key Moments
Autophagy cleans cells, adapting to stress and preventing disease. Fasting & mimetics enhance it, impacting cancer & aging.
Key Insights
Autophagy is a cellular process for recycling damaged components, crucial for adaptation to stress and cell survival.
Nutrient deprivation, particularly hunger, is a primary inducer of autophagy, mediated by sensing pathways like mTOR and AMP kinase.
Protein acetylation plays a key role in regulating autophagy, with reduced acetylation often stimulating the process.
Fasting, especially prolonged, can induce autophagy, though the precise minimum duration in humans remains under investigation.
Specific types of autophagy, such as mitophagy, target and degrade damaged mitochondria, crucial for preventing neurodegenerative diseases.
Autophagy is implicated in cancer, acting as a double-edged sword: it can suppress early oncogenesis but also aid cancer cell survival under stress.
THE MECHANISM AND PURPOSE OF AUTOPHAGY
Autophagy, meaning 'self-eating,' is a fundamental cellular process where the cell sequesters and digests its own damaged components, like organelles and protein aggregates. This process, visible under microscopy, involves the formation of autophagosomes that fuse with lysosomes. The primary goal is not self-destruction, but rather adaptation to stress, resource recycling, and maintaining cellular homeostasis, ultimately preventing cell death.
SIGNALS THAT TRIGGER AUTOPHAGY
Autophagy is predominantly triggered by cellular stress, with nutrient deprivation being a key physiological inducer. This includes the absence of nutrients, growth factors, or oxygen. These signals activate internal sensing pathways, such as reduced ATP levels activating AMP kinase and amino acid scarcity inhibiting mTOR. A crucial biochemical link is the cytosolic acetyl-CoA pool, which directly influences protein acetylation, a major regulator of autophagy initiation.
AUTOPHAGY AND METABOLIC REGULATION
The process of autophagy is tightly linked to cellular metabolism. Reduced nutrient availability leads to a decrease in acetyl-CoA, resulting in protein deacetylation. This deacetylation activates key pathways that promote autophagy. Interestingly, this common regulatory mechanism through acetylation integrates signals from various nutrient sensing pathways, providing an efficient way to stimulate the autophagic machinery in response to diverse metabolic stresses.
INVESTIGATING AUTOPHAGY IN HUMANS AND ANIMALS
While fasting in mice can induce autophagy relatively quickly, determining the precise minimum fasting duration for significant autophagy induction in humans is challenging. Studies on circulating leukocytes suggest a need for several days of fasting. Research into calorie restriction mimetics, like spermidine and resveratrol, shows promise in inducing autophagy pharmacologically, offering alternative avenues for therapeutic intervention.
SPECIFIC TYPES OF AUTOPHAGY AND THEIR ROLES
Beyond general macroautophagy, specialized forms exist, such as mitophagy, which targets damaged mitochondria. Dysfunctional mitochondria can release reactive oxygen species and trigger apoptosis. Mitophagy is essential for clearing these defective organelles, promoting mitochondrial biogenesis and maintaining cellular energy production. This selective organelle turnover is crucial for preventing age-related diseases and is also involved in developmental metabolic reprogramming.
AUTOPHAGY IN NEURODEGENERATION AND AGING
Autophagy plays a critical role in combating neurodegenerative diseases, which often stem from the accumulation of toxic protein aggregates or defects in cellular clearance machinery. Enhancing autophagy can help clear these aggregates, such as amyloid-beta and alpha-synuclein, offering a potential therapeutic strategy. By removing damaged mitochondria and protein clumps, autophagy contributes to slowing the aging process and maintaining cellular health.
THE COMPLEX ROLE OF AUTOPHAGY IN CANCER
Autophagy's role in cancer is complex. Initially, its suppression can promote oncogenesis by increasing genomic instability. However, established cancer cells often reactivate autophagy to survive the stressful microenvironment, including nutrient scarcity and therapeutic insults. While some drugs inhibiting autophagy are used in cancer treatment, their efficacy is often debated, and the process's interaction with the immune system is also crucial for long-term therapeutic success.
AUTOPHAGY, IMMUNITY, AND CANCER THERAPY
Interestingly, autophagy can enhance anti-cancer immunity by facilitating the release of extracellular ATP, which signals to immune cells. Chemotherapy, when combined with autophagy induction, can lead to more durable anti-cancer effects by stimulating this immune response. This highlights a synergistic potential between autophagy-inducing interventions, including fasting mimetics, and immunotherapies for cancer treatment.
FASTING MIMETICS AND DIETARY INTERVENTIONS
Caloric restriction mimetics, such as hydroxycitrate, resveratrol, and spermidine, aim to replicate the benefits of fasting and caloric restriction. These compounds can induce protein deacetylation and stimulate autophagy. Spermidine, found in fermented foods, has shown promise in extending lifespan in animal models and may help mitigate weight gain even on a high-fat diet, potentially through autophagy-dependent mechanisms.
PERSONAL PRACTICES AND FUTURE DIRECTIONS
Dr. Kroemer practices intermittent fasting (one meal a day) and incorporates foods rich in spermidine and resveratrol. He also undertakes periodic prolonged fasts. Coffee polyphenols have also been shown to induce autophagy. Future research directions include further elucidating the molecular details of these processes, establishing optimal therapeutic interventions in humans, and exploring the synergistic effects of autophagy induction with existing treatments.
Mentioned in This Episode
●Supplements
●Products
●Software & Apps
●Tools
●Organizations
●Concepts
●People Referenced
Common Questions
Autophagy is a cellular process where the cell digests its own components, like damaged organelles and protein aggregates, to recycle materials and generate energy. It involves the formation of an autophagosome, which fuses with a lysosome for degradation.
Topics
Mentioned in this video
Diseases like Alzheimer's and Parkinson's are often caused by toxic protein aggregates or deficiencies in autophagy machinery, making autophagy stimulation a potential therapeutic strategy.
A pathway crucial for marking damaged mitochondria for removal via mitophagy, implicated in Parkinson's disease.
Byproducts of mitochondrial dysfunction that can cause cellular damage and are increased when mitophagy is inhibited.
The process by which the immune system identifies and eliminates abnormal or pre-malignant cells, which cancer cells must evade to survive. Autophagy plays a role in facilitating this evasion.
The process by which normal cells are transformed into cancer cells, which can involve initial suppression of autophagy that is later reactivated for survival.
Substances that induce similar biochemical changes to starvation or fasting, promoting autophagy by mechanisms like inhibiting ATP citrate lyase, acetyltransferases, or activating sirtuins.
The academic institution where Dr. Guido Kroemer is a professor.
A protein marker used to study autophagy. Its redistribution from a diffuse pattern to a punctate pattern indicates autophagosome formation and is used as a biomarker for autophagy.
An enzyme that generates cytosolic acetyl-CoA, inhibiting it with compounds like hydroxycitrate reduces acetyl-CoA levels, leading to protein deacetylation and autophagy.
A process associated with the accumulation of damage and defective components within cells, which autophagy helps to mitigate.
While mentioned briefly at the start as a field Dr. Kroemer publishes in, it is not a primary topic of discussion regarding autophagy in this specific segment.
An antimalarial drug and lysosomal inhibitor that was initially thought to inhibit autophagy in cancer treatment, but its mechanism is broader than just autophagy inhibition.
A compound that inhibits ATP citrate lyase, reducing cytosolic acetyl-CoA and promoting protein deacetylation and autophagy. It is a caloric restriction mimetic.
A conserved reaction to bacterial infection where organisms reduce activity and food intake, which can involve autophagy induction to avoid excessive inflammation.
A protein acetyltransferase that plays a significant role in autophagy regulation. Inhibitors like Brahmadine can cause deacetylation and induce autophagy.
A group of individuals practicing calorie restriction, which was referenced in the context of a study measuring autophagy biomarkers in muscle biopsies.
A specialized form of autophagy targeting peroxisomes for degradation.
A type of cancer where inhibition of autophagy is noted to be sufficient to cause oncogenesis.
A natural compound that inhibits EP300, leading to deacetylation and autophagy induction. It is a type of caloric restriction mimetic.
The website for Dr. Guido Kroemer's research laboratory, where people can find more information about his work.
More from FoundMyFitness
View all 92 summaries
2 minWatch my episode with Dr. Charles Brenner
115 minHow To Boost NAD Levels To Fight Inflammation, Improve Recovery, and Slow Aging
92 minDr. Rhonda Patrick: Maximizing Healthspan with Exercise, Sauna, & Cold Exposure
131 minWhy Vigorous Exercise Is 4–10x More Effective Than Moderate (New Evidence)
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free